People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · AI / ML, Healthtech, Hospitals and Physicians, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clinigence Holdings, Inc. | — | AI / ML | Growth/Late | $2.5B | $56.0M | 2018 |
| Apollo Medical Holdings, Inc. | — | Healthtech | Series D+ | $312.8M | $11.2M | 2009 |
| Oncology Institute, Inc. | — | Hospitals and Physicians | Series D+ | $126.4M | $144.8M | 2022 |
| Tapjoy, Inc. | — | Other Technology | Series B | $30.1M | $458.3M | 2011 |
| FlyBy Media, Inc. | — | Other Technology | Series A | $25.1M | $166.2M | 2013 |
| Drobo, Inc. | — | Other Technology | Seed | $2.5M | $85.2M | 2015 |
| UE LifeSciences Inc. | — | Other Health Care | Pre-Seed | $480K | $7.5M | 2021 |
Mihir Shah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mihir Shah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Warren Hosseinion | 2 | 4 |
| Mark Fawcett | 2 | 2 |
| Eric Chin | 1 | 17 |
| Matthew Miller | 1 | 15 |
| MICHAEL CHANG | 1 | 13 |
| Jonathan Perl | 1 | 10 |
| Mark Leschly | 1 | 9 |
| Cole Van Nice | 1 | 7 |
| David Schmidt | 1 | 7 |
| Matthew Young | 1 | 7 |
| Michael Bowen | 1 | 6 |
| Douglas Pepper | 1 | 6 |
| Luis Llovera | 1 | 5 |
| Matthew McCooe | 1 | 5 |
| Mark Pacala | 1 | 5 |
| Randy Socol | 1 | 4 |
| Joseph Del Guercio | 1 | 4 |
| Michael Banks | 1 | 4 |
| Mohit Kaushal | 1 | 4 |
| Paul Santinelli | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.